Moreover, MI promoted myocardial fibrosis dramatically, by increasing collagen deposition and upregulated the expression of fibrotic markers including MMP9, collagen type I, and α-SMA, the effects of which were alleviated by FSTL1 administration (Figures 4A–H). Here, ACTA1 is linked to Myocardial fibrosis.